Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): A pilot randomised controlled trial

Trials

Volumn 18, Issue 1, 2017, Pages

  Chan, Raymond J ^a,b,c   Northfield, Sarah ^a,b,c   Larsen, Emily ^a,c   Mihala, Gabor ^b,c   Ullman, Amanda ^a,c   Hancock, Peter ^a   Marsh, Nicole ^a,c   Gavin, Nicole ^a,c   Wyld, David ^a,b,d   Allworth, Anthony ^a   Russell, Emily ^a   Choudhury, Md Abu ^c   Flynn, Julie ^a,c   Rickard, Claire M ^a,c  

^a METRO NORTH HOSPITAL AND HEALTH SERVICE   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Catheterization; Central venous; Complications; Dressing and securement methods; Peripherally inserted central catheter (PICC); Randomised controlled trials; Vascular access devices

Indexed keywords

CHLORHEXIDINE GLUCONATE; POLYURETHAN; TISSUE ADHESIVE; CHLORHEXIDINE; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BIOLOGICAL DRESSING; CATHETER REMOVAL; CENTRAL VENOUS CATHETERIZATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST; DEVICE FAILURE; FEASIBILITY STUDY; FEEDBACK SYSTEM; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PERIPHERAL VENOUS CATHETER; PILOT STUDY; PROGRAM ACCEPTABILITY; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SAFETY; SUTURELESS TECHNIQUE; VASCULAR ACCESS DEVICE; ADVERSE DEVICE EFFECT; AGED; ANALOGS AND DERIVATIVES; BANDAGE; CATHETER INFECTION; CATHETER OCCLUSION; CATHETERIZATION; CENTRAL VENOUS CATHETER; COMPARATIVE STUDY; DEVICE REMOVAL; DEVICES; EQUIPMENT DESIGN; HEALTH PERSONNEL ATTITUDE; INDWELLING CATHETER; MICROBIOLOGY; QUEENSLAND; TIME FACTOR; TREATMENT FAILURE;

ADULT; AGED; ANTI-INFECTIVE AGENTS, LOCAL; ATTITUDE OF HEALTH PERSONNEL; BANDAGES; CATHETER OBSTRUCTION; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; CHLORHEXIDINE; DEVICE REMOVAL; EQUIPMENT DESIGN; FEASIBILITY STUDIES; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PILOT PROJECTS; POLYURETHANES; QUEENSLAND; TIME FACTORS; TISSUE ADHESIVES; TREATMENT FAILURE;

EID: 85030308079     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-017-2207-x     Document Type: Article

References (36)

1. Schiffer CA, Mangu PB, Wade JC, Camp-Sorrell D, Cope DG, El-Rayes BF, Gorman M, Ligibel J, Mansfield P, Levine M. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31(10):1357-70.
2. Cotogni P, Pittiruti M. Focus on peripherally inserted central catheters in critically ill patients. World J Crit Care Med. 2014;3(4):80-94.
3. Chopra V, Flanders SA, Saint S, Woller SC, O'Grady NP, Safdar N, Trerotola SO, Saran R, Moureau N, Wiseman S, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA Appropriateness Method. Ann Intern Med. 2015;163(6 Suppl):S1-40.
4. Yap Y-S, Karapetis C, Lerose S, Iyer S, Koczwara B. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting. Eur J Cancer Care. 2006;15(4):342-7.
5. Yamamoto AJ, Solomon JA, Soulen MC, Tang J, Parkinson K, Lin R, Schears GJ. Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol. 2002;13:77-81.
6. Bolz K, Ramritu P, Halton K, Cook D, Graves N. Management of central venous catheters in adult intensive care units in Australia: policies and practices. Healthc Infect. 2008;13(2):48-55.
7. Ullman AJ, Marsh N, Mihala G, Cooke M, Rickard CM. Complications of central venous access devices: a systematic review. Pediatrics. 2015;136(5):e1331-44.
8. Chopra V, Anand S, Hickner A, Buist M, Rogers MA, Saint S, Flanders SA. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382(9889):311-25.
9. Frankel A. Temporary access and central venous catheters. Eur J Vasc Endovasc Surg. 2006;31(4):417-22.
10. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Barth RL. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteraemia and fungaemia in adults. Clin Infect Dis. 1997;24(4):584-602.
11. Bong JJ, Kite P, Wilco MH, McMahon MJ. Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters: a randomised controlled trial. J Clin Pathol. 2003;56(10):731-5.
12. Walz JM, Memtsoudis SG, Heard SO. Prevention of central venous catheter bloodstream infections. J Intensive Care Med. 2010;25(3):131-8.
13. Russell E, Chan RJ, Marsh N, New K. A point prevalence study of cancer nursing practices for managing intravascular devices in an Australian tertiary cancer center. Eur J Oncol Nurs. 2014;18(3):231-5.
14. Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, Mihala G, Rickard CM. Dressings and securement devices for central venous catheters (CVC). Cochrane Database Syst Rev. 2015;9, CD010367.
15. Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31(2):180-91.
16. Julious S. Sample size of 12 per group rule of thumb for pilot study. Pharm Stat. 2005;4:287-91.
17. Smith B, Royer TI. New standards for improving peripheral I.V. catheter securement. Nursing. 2007;37(3):72-4.
18. Campbell H, Carrington M. Peripheral IV cannula dressings: advantages and disadvantages. Br J Nurs. 1999;8(21):1420-7.
19. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing: a meta-analysis of the infection risks. JAMA. 1992;267(15):2072-6.
20. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA. 1987;258(17):2396-403.
21. Webster J, Gillies D, O'Riordan E, Sherriff KL, Rickard CM. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev. 2011;11, CD003827. https://www.ncbi.nlm.nih.gov/pubmed/22071809.
22. Frey AM, Schears GJ. Why are we stuck on tape and suture? A review of catheter securement devices. J Infus Nurs. 2006;29(1):34-8.
23. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, O'Heard S, Lipsett PA, Masur H, Mermel LA, Pearson ML, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162-93.
24. Teichgräber UK, de Bucourt M, Gebauer B, Streitparth F, Hamm B, Enzweiler C. Effectiveness of sutureless percutaneous placement of cuffed tunneled hemodialysis catheters applying StatLock attachment devices. J Vasc Access. 2011;12(1):17-20.
25. O'Brien G, Buckley K, Vanwalleghem G, Vanrenterghem D, Dharma H, Winter RL, Douglass J. A multi-centre, prospective, clinical in-market evaluation to assess the performance of Opsite Post-Op Visible dressings. Int Wound J. 2010;7(5):329-37.
26. Flippo P, Lee J. Clinical Evaluation of the Sorbaview SHIELD securement device used on peripheral intravenous catheters in the acute care setting. J Assoc Vasc Access. 2011;16(2):1-7.
27. Singer AJ, Thode HCJ. A review of the literature on octylcyanoacrylate tissue adhesive. Am J Surg. 2004;187(2):238-48.
28. Aukerman DF, Sebastianelli WJ, Nashelsky J. Clinical inquiries. How does tissue adhesive compare with suturing for superficial lacerations? J Fam Pract. 2005;54(4):378.
29. Dobbins BM, Wilcox MH, McMahon MJ. Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal. Lancet. 1999;354(9189):1504-7.
30. Eisenberg JM, Rose JD, Weinstein AJ. Routine blood cultures from febrile outpatients: Use in detecting bacteremia. JAMA. 1976;236(25):2863-5.
31. Laupland KB, Church DL, Gregson DB. Blood cultures in ambulatory outpatients. BMC Infect Dis. 2005;5(1):35.
32. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45.
33. Centers for Disease Control and Prevention and National Healthcare Safety Network. In: Prevention. CfDCa, editor. July 2013 CDC/NHSN Protocol Clarifications. 2013
34. Goossens GA, De Waele Y, Jerome M, Fieuws S, Janssens C, Stas M, Moons P. Diagnostic accuracy of the Catheter Injection and Aspiration (CINAS) classification for assessing the function of totally implantable venous access devices. Support Care Cancer. 2016;24(2):755-61.
35. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710-8.
36. Rickard CM, Edwards M, Spooner AJ, Mihala G, Marsh N, Best J, Wendt T, Rapchuk I, Gabriel S, Thomson B, et al. A 4-arm randomized controlled pilot trial of innovative solutions for jugular central venous access device securement in 221 cardiac surgical patients. J Crit Care. 2016;36:35-42.